Apoptosis: Opportuniti- es in Cancer and ...
The Future of Ophthalmolo- gy Therapeutic- s, ...
This report explores trends in the market for biologics and biosimilars and identifies product improvement technologies offering a source of competitive advantage.
*50% discount on this report for SMi's conference attendees*
Published July 2009
Authors Sreten Bogdanovic and Beata Langlands
Pages 27
Tables 44
Click for: Brochure with Table of Contents
Click for: Sample Section (4.3.3, PDF)
Contents
Executive Summary
Chapter 1 First-generation biologics
Chapter 2 Biosimilars and follow-on biologics
Chapter 3 Biobetters
Chapter 4 Peptide, protein and other biosimilar targets
Chapter 5 Monoclonal antibody biosimilar targets
Chapter 6 Company profiles
Chapter 7 Market analysis
The following other reports offer comprehensive assessments of the therapy areas relevant to this report:
Anemia (renal/chemo) :
Chronic Kidney Disease - Drug Pipeline Analysis and Market Forecasts to 2016
Anemia - Drug Pipeline Analysis and Market Forecasts to 2016
Neutropenia :
Neutropenia - Drug Pipeline Analysis and Market Forecasts to 2016
Diabetes (types 1 & 2) :
Drug Delivery: Heading Towards A Needle Free Future
Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015
Type 2 Diabetes - Drug Pipeline Analysis and Market Forecasts to 2016
Type 1 Diabetes - Drug Pipeline Analysis and Market Forecasts to 2016
Cancer :
Non-Small-Cell Lung Cancer (NSCLC) - Drug Pipeline Analysis and Market Forecasts to 2015
Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015
Prostate Cancer - Drug Pipeline Analysis and Market Forecasts to 2015
Breast Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Colorectal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016
Rheumatoid arthritis :
Rheumatoid Arthritis - Drug Pipeline Analysis and Market Forecasts to 2015
Multiple sclerosis :
Multiple Sclerosis - Drug Pipeline Analysis and Market Forecasts to 2015
Osteoporosis :
Osteoporosis - Drug Pipeline Analysis and Market Forecasts to 2016
Hemophilia A/B :
Hemophilia - Drug Pipeline Analysis and Market Forecasts to 2016
Growth hormone deficiency :
Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016
Cystic fibrosis :
Cystic Fibrosis - Drug Pipeline Analysis and Market Forecasts to 2015
Hepatitis B/C infections :
Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015
Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016
